Novogene Co (688315.SS) Stock Price

Novogene Co Price

SSE·CLOSED
13.88CNY+0.66 (+4.87 %)
Market closed

Over the last 6 years Novogene Co grew revenue by 12.3% annually, reaching 2.11 B CNY. Earnings per share have grown at 12.0% per year over the last 6 years. For Novogene Co, the net margin of 9.3% is up versus 2.4% a few years ago. At today's price the dividend yield works out to roughly 0.34%. The payout ratio is around 10% of earnings. The consensus 12-month price target for Novogene Co is 15.79 CNY, about 13.8% above where the stock trades today. Of 6 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 16% above its 52-week low.

Novogene Co stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Novogene Co over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Novogene Co stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Novogene Co's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Novogene Co Stock Price History
DateNovogene Co Price
7/15/202613.88 CNY
7/14/202613.22 CNY
7/13/202612.82 CNY
7/10/202613.13 CNY
7/9/202612.71 CNY
7/8/202612.67 CNY
7/7/202612.85 CNY
7/6/202613.44 CNY
7/3/202613.40 CNY
7/2/202613.15 CNY
7/1/202613.41 CNY
6/30/202612.51 CNY
6/29/202612.65 CNY
6/26/202611.96 CNY
6/25/202612.52 CNY
6/24/202612.78 CNY
6/23/202612.87 CNY
6/22/202612.02 CNY
6/18/202612.62 CNY
6/17/202612.24 CNY
6/16/202612.17 CNY
6/15/202612.24 CNY
6/12/202612.45 CNY
6/11/202612.17 CNY
6/10/202612.77 CNY
6/9/202612.95 CNY
6/8/202612.93 CNY
6/5/202613.48 CNY
6/4/202613.32 CNY
6/3/202613.79 CNY
6/2/202614.09 CNY
6/1/202614.46 CNY
5/29/202614.23 CNY
5/28/202614.90 CNY
5/27/202614.85 CNY
5/26/202615.10 CNY
5/25/202615.06 CNY
5/22/202614.92 CNY
5/21/202614.94 CNY
5/20/202615.12 CNY
5/19/202615.14 CNY
5/18/202614.91 CNY
5/15/202615.05 CNY
5/14/202615.01 CNY
5/13/202615.64 CNY
5/12/202615.55 CNY
5/11/202616.00 CNY
5/8/202615.12 CNY
5/7/202614.43 CNY
5/6/202614.37 CNY
4/30/202614.23 CNY
4/29/202614.52 CNY
4/28/202614.40 CNY
4/27/202614.56 CNY
4/24/202614.14 CNY
4/23/202614.19 CNY
4/22/202614.40 CNY
4/21/202614.18 CNY
4/20/202614.47 CNY
4/17/202614.48 CNY
4/16/202614.34 CNY
4/15/202614.53 CNY
4/14/202614.68 CNY
4/13/202614.35 CNY
4/10/202614.50 CNY
4/9/202614.31 CNY
4/8/202614.44 CNY
4/7/202614.08 CNY
4/3/202613.90 CNY
4/2/202614.29 CNY
4/1/202614.45 CNY
3/31/202613.89 CNY
3/30/202613.92 CNY
3/27/202613.79 CNY
3/26/202613.36 CNY
3/25/202613.63 CNY
3/24/202613.56 CNY
3/23/202613.07 CNY
3/20/202613.75 CNY
3/19/202614.08 CNY
3/18/202614.48 CNY
3/17/202614.21 CNY
3/16/202614.46 CNY
3/13/202614.31 CNY
3/12/202614.38 CNY
3/11/202614.44 CNY
3/10/202614.58 CNY
3/9/202614.27 CNY
3/6/202614.42 CNY
3/5/202614.19 CNY
2/27/202615.37 CNY
2/26/202615.20 CNY
2/25/202615.35 CNY
2/24/202615.22 CNY
2/13/202615.29 CNY
2/12/202615.64 CNY
2/11/202615.58 CNY
2/10/202615.68 CNY
2/9/202615.78 CNY
2/6/202615.46 CNY
2/5/202615.54 CNY
2/4/202615.92 CNY
2/3/202615.88 CNY
2/2/202615.23 CNY
1/30/202615.65 CNY
1/29/202615.90 CNY
1/28/202615.95 CNY
1/27/202616.37 CNY
1/26/202617.02 CNY
1/23/202616.97 CNY
1/22/202615.00 CNY
1/21/202615.07 CNY
1/20/202614.78 CNY
1/19/202614.97 CNY
1/16/202615.22 CNY
1/15/202615.92 CNY
1/14/202616.03 CNY
1/13/202615.96 CNY
1/12/202615.83 CNY
1/9/202615.00 CNY
1/8/202614.12 CNY
1/7/202613.88 CNY
1/6/202614.05 CNY
1/5/202613.98 CNY
12/31/202513.27 CNY
12/30/202513.26 CNY
12/29/202513.33 CNY
12/26/202513.40 CNY
12/25/202513.54 CNY
12/24/202513.49 CNY
12/23/202513.40 CNY
12/22/202513.53 CNY
12/19/202513.57 CNY
12/18/202513.52 CNY
12/17/202513.17 CNY
12/16/202513.05 CNY
12/15/202513.17 CNY
12/12/202513.39 CNY
12/11/202513.30 CNY
12/10/202513.53 CNY
12/9/202513.56 CNY
12/8/202513.69 CNY
12/5/202513.69 CNY
12/4/202513.42 CNY
12/3/202513.56 CNY
12/2/202513.80 CNY
12/1/202513.82 CNY
11/28/202513.69 CNY
11/27/202513.57 CNY
11/26/202513.58 CNY
11/25/202513.70 CNY
11/24/202513.60 CNY
11/21/202513.39 CNY
11/20/202513.96 CNY
11/19/202514.28 CNY
11/18/202514.58 CNY
11/17/202514.46 CNY
11/14/202514.85 CNY
11/13/202514.70 CNY
11/12/202514.65 CNY
11/11/202514.72 CNY
11/10/202514.70 CNY
11/7/202514.55 CNY
11/6/202514.66 CNY
11/5/202514.70 CNY
11/4/202514.80 CNY
11/3/202515.04 CNY
10/31/202514.65 CNY
10/30/202514.14 CNY
10/29/202514.34 CNY
10/28/202514.51 CNY
10/27/202514.49 CNY
10/24/202514.57 CNY
10/23/202514.78 CNY
10/22/202514.72 CNY
10/21/202514.90 CNY
10/20/202514.43 CNY
10/17/202514.25 CNY
10/16/202514.67 CNY
10/15/202514.90 CNY
10/14/202514.77 CNY
10/13/202515.02 CNY
10/10/202515.39 CNY
10/9/202515.68 CNY
9/30/202515.83 CNY
9/29/202515.35 CNY
9/26/202515.32 CNY
9/25/202515.54 CNY
9/24/202515.32 CNY
9/23/202514.98 CNY
9/22/202515.41 CNY
9/19/202515.50 CNY
9/18/202515.84 CNY
9/17/202515.83 CNY
9/16/202516.13 CNY
9/15/202516.12 CNY
9/12/202516.33 CNY
9/11/202516.66 CNY
9/10/202517.17 CNY
9/9/202516.13 CNY
9/8/202515.89 CNY
9/5/202515.11 CNY
9/4/202514.85 CNY
9/3/202515.15 CNY
9/2/202515.38 CNY
9/1/202515.80 CNY
8/29/202515.53 CNY
8/28/202515.52 CNY
8/27/202515.85 CNY
8/26/202516.24 CNY
8/25/202516.49 CNY
8/22/202516.40 CNY
8/21/202516.02 CNY
8/20/202516.05 CNY
8/19/202516.28 CNY
8/18/202516.42 CNY
8/15/202516.36 CNY
8/14/202516.36 CNY
8/13/202516.81 CNY
8/12/202516.74 CNY
8/11/202516.73 CNY
8/8/202516.11 CNY
8/7/202516.39 CNY
8/6/202516.51 CNY
8/5/202516.39 CNY
8/4/202516.39 CNY
8/1/202516.29 CNY
7/31/202516.32 CNY
7/30/202516.39 CNY
7/29/202516.75 CNY
7/28/202516.28 CNY
7/25/202516.11 CNY
7/24/202515.94 CNY
7/23/202515.63 CNY
7/22/202515.56 CNY
7/21/202515.79 CNY
7/18/202515.89 CNY
7/17/202515.86 CNY
Access this data via the Eulerpool API
Get Free API Key

Novogene Co Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
1.49 B CNY
49.00 M CNY
36.50 M CNY
Jan 1, 2021
1.87 B CNY
228.30 M CNY
225.00 M CNY
Jan 1, 2022
1.93 B CNY
210.58 M CNY
177.23 M CNY
Jan 1, 2023
2.00 B CNY
183.77 M CNY
178.06 M CNY
Jan 1, 2024
2.11 B CNY
201.83 M CNY
196.79 M CNY
Jan 1, 2025 (e)
2.28 B CNY
234.83 M CNY
200.83 M CNY
Jan 1, 2026 (e)
2.54 B CNY
265.13 M CNY
233.95 M CNY
Jan 1, 2027 (e)
2.87 B CNY
304.01 M CNY
277.43 M CNY

Novogene Co Income Statement, Balance Sheet, Cash Flow Statement

Last updated Jul 16, 2026, 9:17 PM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
NET INCOMEM CNY
NET INCOME GROWTH%
DIV.CNY
DIV. GROWTH%
SHARESM
20182019202020212022202320242025e2026e2027e
1.051.531.491.871.932.002.112.282.542.87
–45.68-2.8725.233.164.005.447.8611.4213.13
42.5539.1134.7042.5044.1042.5643.4443.4443.4443.44
0.450.600.520.790.850.850.920.991.101.25
97.00114.0036.00225.00177.00178.00196.00200.00233.00277.00
–17.53-68.42525.00-21.330.5610.112.0416.5018.88
––––0.060.050.050.050.050.05
–––––-16.67––––
400.20400.20400.20400.20400.20416.20409.98409.98409.98409.98
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Novogene Co generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Novogene Co retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Novogene Co's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Novogene Co has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Novogene Co's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Novogene Co stock margins

The Novogene Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Novogene Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Novogene Co.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
34.74 %
3.29 %
2.45 %
Jan 1, 2021
42.54 %
12.23 %
12.06 %
Jan 1, 2022
44.09 %
10.94 %
9.20 %
Jan 1, 2023
42.58 %
9.18 %
8.89 %
Jan 1, 2024
43.46 %
9.56 %
9.32 %
Jan 1, 2025 (e)
43.46 %
10.31 %
8.82 %
Jan 1, 2026 (e)
43.46 %
10.45 %
9.22 %
Jan 1, 2027 (e)
43.46 %
10.59 %
9.67 %

Novogene Co Stock Revenue, EBIT, Earnings per Share

The Novogene Co earnings per share therefore indicates how much revenue Novogene Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
3.72 CNY
0.12 CNY
0.09 CNY
Jan 1, 2021
4.66 CNY
0.57 CNY
0.56 CNY
Jan 1, 2022
4.81 CNY
0.53 CNY
0.44 CNY
Jan 1, 2023
4.81 CNY
0.44 CNY
0.43 CNY
Jan 1, 2024
5.15 CNY
0.49 CNY
0.48 CNY
Jan 1, 2025 (e)
5.55 CNY
0.57 CNY
0.49 CNY
Jan 1, 2026 (e)
6.19 CNY
0.65 CNY
0.57 CNY
Jan 1, 2027 (e)
7.00 CNY
0.74 CNY
0.68 CNY

Novogene Co business model & stock analysis

Novogene Co Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Novogene Co historical P/E ratio, EBIT multiple, and P/S ratio

Novogene Co annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Novogene Co shares outstanding

The number of shares of Novogene Co was 409.98 M in 2025. This indicates how many shares Novogene Co is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
400.20 M Stocks
Jan 1, 2021
400.20 M Stocks
Jan 1, 2022
400.20 M Stocks
Jan 1, 2023
416.20 M Stocks
Jan 1, 2024
409.98 M Stocks
Jan 1, 2025 (e)
409.98 M Stocks
Jan 1, 2026 (e)
409.98 M Stocks
Jan 1, 2027 (e)
409.98 M Stocks

Novogene Co Dividend History

4 years of dividend payments · 2 consecutive increases

YearAnnual DividendYoY ChangePayments
20250.05CNY↑ 5.3%1×
Jun 10, 20250.05CNY↑ 5.3%1/1
20240.05CNY↑ 1.1%1×
20230.05CNY↓ 21.7%1×
20220.06CNY—1×

Novogene Co dividend history and estimates

In 2025, Novogene Co paid a dividend amounting to 0.05 CNY. Dividend means that Novogene Co distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022
0.06 CNY
0.00 CNY
Jan 1, 2023
0.05 CNY
0.00 CNY
Jan 1, 2024
0.05 CNY
0.00 CNY
Jan 1, 2025
0.05 CNY
0.00 CNY
Jan 1, 2026 (e)
0.00 CNY
0.05 CNY
Jan 1, 2027 (e)
0.00 CNY
0.05 CNY

Novogene Co dividend payout ratio

In 2025, Novogene Co had a payout ratio of 10.21%. The payout ratio indicates the percentage of the company's profits that Novogene Co distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
11.48 %
Jan 1, 2021
11.48 %
Jan 1, 2022
13.55 %
Jan 1, 2023
10.99 %
Jan 1, 2024
9.90 %
Jan 1, 2025 (e)
10.21 %
Jan 1, 2026 (e)
8.76 %
Jan 1, 2027 (e)
7.39 %

Current Novogene Co forecasts and price targets in July 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy66.67 % (4)
Hold33.33 % (2)
Sell0.00 % (0)
12M Price Target
15.79
Last Price
13.88
Currency
CNY
12M Return Potential
13.76 %
LTM Return
0 %

Novogene Co shareholder structure

% Name
52.39579%
Li (Ruiqiang)
Li (Ruiqiang)
12.58455%
Beijing Zhiyuan Hegu Investment Management Center (Limited Partnership)
Beijing Zhiyuan Hegu Investment Management Center (Limited Partnership)
4.42135%
SDIC Innovation Investment Management Co., Ltd.
SDIC Innovation Investment Management Co., Ltd.
3.01168%
Beijing Nuohe Hegu Investment Management Center LP
Beijing Nuohe Hegu Investment Management Center LP
1.31375%
Jiang (Zhi)
Jiang (Zhi)
0.93111%
Penghua Fund Management Co., Ltd.
Penghua Fund Management Co., Ltd.
...

Novogene Co Executives and Management Board

QW

Mr. Qifeng Wang

(43)

Deputy General Manager, Secretary of the Board, Director

Compensation1.02 M CNY
JS

Mr. Jiashan Shi

(39)

Chief Financial Officer

Compensation830,200.00 CNY
DW

Mr. Dawei Wang

(39)

Deputy General Manager

Compensation714,700.00 CNY
RL

Mr. Ruiqiang Li

(42)

Chairman of the Board, General Manager

Compensation428,300.00 CNY
YL

Ms. Yanping Li

(47)

Deputy General Manager

Frequently asked questions about Novogene Co

Analysts currently set an average price target of 16.10 CNY for the Novogene Co stock (median: 15.79 CNY), implying +16.0 % versus the latest price. The consensus is based on 6 analyst ratings.

Novogene Co Analyst Price Targets 2026

All fundamentals and in-depth analysis of Novogene Co

Our stock analysis for Novogene Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Novogene Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Novogene Co Stock
Novogene Co Revenue→
Novogene Co Stock
Novogene Co Net Income→
Novogene Co Stock
Novogene Co P/E→
Novogene Co Stock
Novogene Co P/S→
Novogene Co Stock
Novogene Co EBIT→
Novogene Co Stock
Novogene Co Dividend→
Novogene Co Stock
Novogene Co Directors Dealings→
Novogene Co Stock
Novogene Co Stocks→
Novogene Co Stock
Novogene Co Market capitalization→
Novogene Co Stock
Novogene Co Debt→
Novogene Co Stock
Novogene Co Liabilities→
Novogene Co Stock
Novogene Co Equity→
Novogene Co Stock
Novogene Co AAQS→
Novogene Co Stock
Novogene Co Employees→
Novogene Co Stock
Novogene Co ROE→
Novogene Co Stock
Novogene Co ROA→
Novogene Co Stock
Novogene Co ROCE→
Novogene Co Stock
Novogene Co News→
Novogene Co Stock
Novogene Co Analyst Price Targets→

Health Stocks

Novolog Pharm Up 1966NovocureNovoprotein ScientificNovo Nordisk A/SNoxopharmNovo Nordisk A/SNozha International Hospital SAENovo Integrated SciencesNRX PharmaceuticalsNovember 26,NuCanaNovelstem InternationalAll Stocks A–Z →